• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Nestlé Health Licenses Codexis’ CDX-6114

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Progenics Launches Mfg. Ops in NJ

    Charles River to Pay $510M for Citoxlab
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Progenics Launches Mfg. Ops in NJ

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Haselmeier Acquires Drug Manufacturing License

    Emerald Health, Lonza Enter Large-Scale Mfg. Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Recipharm Facilities Ready for EU Serialization

    Andrew Alliance, Sartorius Launch Research Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nestlé Health Licenses Codexis’ CDX-6114

    Personalized Medicine: Getting More Out of Clinical Trials

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    Charles River to Pay $510M for Citoxlab

    West, Swissfillon Enter Drug Delivery Partnership
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Ascendia Pharmaceuticals

    Jubilant HollisterStier Contract Manufacturing & Services

    Alcami

    Aphena Pharma Solutions, Inc.

    Federal Equipment Company
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Ajinomoto Bio-Pharma Services

    Ascendia Pharmaceuticals

    Federal Equipment Company

    Vetter Pharma International GmbH

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Merck KGaA, Cyclica in AI Screening Platform Pact

    Augmented platform is being used to uncover novel targets that are modeled to interact with a small molecule

    Related CONTENT
    • DCAT Sharp Sourcing 2018
    • Adents & Microsoft Launch Adents NovaTrack
    • Abcam, Merck Launch Anti-PD-L1 Antibody Clone
    • Catalent to Acquire Juniper Pharmaceuticals
    • 24 Mylan
    12.06.18
    Merck KGaA has entered into a licensing agreement with Cyclica Inc. for the use of Ligand Express, a cloud-based in silico proteome screening platform. Ligand Express is a structure-based and artificial intelligence (AI) augmented platform that is being used to uncover novel targets that are modeled to interact with a small molecule. The one-year agreement will enable Merck KGaA to quickly and efficiently elucidate mechanisms of action, evaluate safety profiles and explore additional applications for a number of its investigational small molecules, including those identified in highly disease-relevant phenotypic screens.

    "With scientific curiosity at the heart of everything we do, the pursuit of state-of-the-art research techniques and technologies is integral to complement our internal discovery engine," said Belén Garijo, member of the executive board and chief executive officer Healthcare, Merck KGaA, Darmstadt, Germany. "Artificial intelligence has the power to make the previously unimaginable a reality - we are eager to harness these new possibilities to help drive the discoveries that can transform the lives of people affected by difficult-to-treat diseases."

    Traditional development of small molecule therapies focuses on specific, disease-associated protein targets. However, once a drug enters the body, it interacts with dozens, if not hundreds, of proteins before it is eliminated from the body. With Ligand Express, it is possible to capture a unique view of the proteome for a given small molecule. As the technology can model the ways in which a small molecule will interact with all proteins (of known structure), it can help identify both 'on-targets' (interactions that may have a desirable effect on a certain disease), as well as 'off-targets' (interactions that may cause an adverse effect).
    Related Searches
    • discovery
    • chief executive officer
    • merck
    • it
    Suggested For You
    Three Ways Quality Can Impact a Business’s Bottom Line Three Ways Quality Can Impact a Business’s Bottom Line
    AI in Pharma: Transforming Data into Drugs AI in Pharma: Transforming Data into Drugs
    Daiichi Sankyo, Merck, Pfizer Enter Collaboration Daiichi Sankyo, Merck, Pfizer Enter Collaboration
    Improving Pharma R&D Efficiency: The need to transform clinical trials Improving Pharma R&D Efficiency: The need to transform clinical trials
    Rehan Verjee to Lead EMD Serono Rehan Verjee to Lead EMD Serono
    Catalent Completes Juniper Acquisition Catalent Completes Juniper Acquisition
    Top 25 Pharma and Biopharma Companies Top 25 Pharma and Biopharma Companies
    Leap, Merck KGaA, Pfizer Partner for Cancer Leap, Merck KGaA, Pfizer Partner for Cancer
    03	Sanofi 03 Sanofi
    24	Mylan 24 Mylan
    Catalent to Acquire Juniper Pharmaceuticals Catalent to Acquire Juniper Pharmaceuticals
    Abcam, Merck Launch Anti-PD-L1 Antibody Clone Abcam, Merck Launch Anti-PD-L1 Antibody Clone
    Adents & Microsoft Launch Adents NovaTrack Adents & Microsoft Launch Adents NovaTrack
    DCAT Sharp Sourcing 2018 DCAT Sharp Sourcing 2018

    Related Breaking News

    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Jubilant Biosys, Sanofi Expand Collaboration

      Jubilant Biosys, Sanofi Expand Collaboration

      Collaboration aimed at discovery of small molecule inhibitors targeting neurological disorders
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
      Passage Bio Officially Launches

      Passage Bio Officially Launches

      With $115.5M Series A, to develop AAV-delivered therapeutics to treat rare monogenic CNS diseases
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      AbCellera & Novartis Announce Collaboration

      AbCellera & Novartis Announce Collaboration

      AbCellera to apply technology to advance programs on up to ten targets elected by Novartis
      02.15.19


    • Breaking News | Clinical Trials | Industry News | Information Technology
      Boehringer, IBM Explore Blockchain Technology in Clinical Trials

      Boehringer, IBM Explore Blockchain Technology in Clinical Trials

      Aims to improve the quality of clinical trial processes and record keeping
      02.12.19

    • Breaking News | Industry News | Information Technology | Inspections | QA/QC | Regulatory Affairs | Validation
      Top Global Pharma Company to Implement ValGenesis

      Top Global Pharma Company to Implement ValGenesis' VLMS

      Paperless validation system aims to harmonize and standardize the validation process across all its global sites
      02.12.19

    • Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      NeoTX, MedImmune Announce Clinical Collaboration

      NeoTX, MedImmune Announce Clinical Collaboration

      To support Phase 1b/2 studies investigating ANYARA in combination with AstraZeneca's IMFINZI
      02.11.19


    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Eton & Sintetica Enter Supply Agreement

      Eton & Sintetica Enter Supply Agreement

      To obtain U.S. marketing rights to two high-volume, near-term product launch candidates.
      02.11.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      MedPharm & Palvella Expand Partnership

      MedPharm & Palvella Expand Partnership

      For developing a new treatment for the debilitating rare disease, pachyonychia congenita
      02.11.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Evotec & Galapagos Enter Global Collaboration

      Evotec & Galapagos Enter Global Collaboration

      Focused on a novel target for fibrosis and other indications
      02.07.19


    • Breaking News | Industry News | Information Technology
      Sharp Enhances IRT Solution

      Sharp Enhances IRT Solution

      Will invest $650,000; names Eddie Montoya IRT specialist.
      02.07.19

    • Breaking News | Industry News | Information Technology
      ICON Launches Drug Safety Reporting Solution

      ICON Launches Drug Safety Reporting Solution

      Developed on platform deploying rule-based automation for timely delivery of drug safety information
      02.05.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
      Polyphor Awarded $5.6M Grant from CARB-X

      Polyphor Awarded $5.6M Grant from CARB-X

      To support the development of a novel OMPTA candidate to treat the deadliest and most resistant Gram-negative bacterial pathogens
      02.05.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Methods Development | R&D
      Xencor, Genentech Enter Research & Licensing Deal

      Xencor, Genentech Enter Research & Licensing Deal

      To develop and commercialize Novel IL-15 Immune Activating Cytokines
      02.05.19

    • Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Neurotrope & NCI Enter Development Agreement

      Neurotrope & NCI Enter Development Agreement

      To develop a Phase I clinical trial testing the safety and toxicity of Bryostatin-1 in children and young adults with CD22 + leukemia and B-cell lymphoma
      02.04.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      MeiraGTx & Janssen Enter Gene Therapy Collaboration

      MeiraGTx & Janssen Enter Gene Therapy Collaboration

      To develop and commercialize gene therapies for the treatment of inherited retinal diseases
      01.31.19

    Breaking News
    • Nestlé Health Licenses Codexis’ CDX-6114
    • SK, Arvelle Sign $530M Deal for Antiepileptic Drug
    • GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers
    • Progenics Launches Mfg. Ops in NJ
    • Charles River to Pay $510M for Citoxlab
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login